 NEW YORK and LONDON, Jan. 27, 2021 GLOBE NEWSWIRE -- Tiziana Life Sciences plc Nasdaq: TLSA LSE: TILS, a biotechnology company focused on innovative therapeutics for oncology, inflammation, and infectious diseases, today announces that it has filed a universal shelf registration statement on Form F-3 File No. 333-252441 the Registration Statement with the U.S. Securities and Exchange Commission SEC in relation to up to US250,000,000 in market value of its securities. 